Novel role of Egr-1 in nicotine-related neointimal formation. - Wikidata - wikimedia - TriplyDB

Novel role of Egr-1 in nicotine-related neointimal formation.

Novel role of Egr-1 in nicotine-related neointimal formation.

http://www.wikidata.org/entity/Q34307959

about

PET Imaging of the Human Nicotinic Cholinergic Pathway in Atherosclerosis c-Kit signaling determines neointimal hyperplasia in arteriovenous fistulae Low dose nicotine attenuates Aβ neurotoxicity through activation early growth response gene 1 pathway.Nicotine: A Double-Edged Sword in Atherosclerotic Disease.Early growth response-1 in the pathogenesis of cardiovascular disease.STIM-1 and ORAI-1 channel mediate angiotensin-II-induced expression of Egr-1 in vascular smooth muscle cells.Pravastatin attenuates the action of the ETS domain-containing protein ELK1 to prevent atherosclerosis in apolipoprotein E-knockout mice via modulation of extracellular signal-regulated kinase 1/2 signal pathway.Cholinergic anti-inflammatory pathway inhibits neointimal hyperplasia by suppressing inflammation and oxidative stress.cAMP attenuates angiotensin-II-induced Egr-1 expression via PKA-dependent signaling pathway in vascular smooth muscle cells.

P2860

Q26800058-CBAA1DBF-37E8-41D5-9DEC-B8F901B28E62 Q34439804-ADBD193A-0662-4B1F-998A-B96DB8749D54 Q35223747-80FBA138-11F7-42F2-8856-6AE80C2EEC09 Q36721910-CC033700-E883-4A77-9EE9-043D5301216B Q38850831-000C1EA9-6188-47BF-BE4A-5A1893F30553 Q39010799-0415033A-1169-444E-A834-C91237363614 Q46442680-C37CBE49-7522-40D6-9B10-1B8C3D83B24B Q47146561-5CA8BAD4-B0EA-4435-B635-7A9A79D50391 Q51025871-4EF4737F-720C-4145-ACB6-5ED8364191FA

P2860

Novel role of Egr-1 in nicotine-related neointimal formation.

http://www.wikidata.org/entity/Q34307959

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Novel role of Egr-1 in nicotine-related neointimal formation.

@ast

Novel role of Egr-1 in nicotine-related neointimal formation.

@en

Novel role of Egr-1 in nicotine-related neointimal formation.

@nl

type

label

Novel role of Egr-1 in nicotine-related neointimal formation.

@ast

Novel role of Egr-1 in nicotine-related neointimal formation.

@en

Novel role of Egr-1 in nicotine-related neointimal formation.

@nl

prefLabel

Novel role of Egr-1 in nicotine-related neointimal formation.

@ast

Novel role of Egr-1 in nicotine-related neointimal formation.

@en

Novel role of Egr-1 in nicotine-related neointimal formation.

@nl

P1433

Q34307959-08617251-0A5B-4302-BF41-63FA397B2D5E

P1476

Q34307959-3B6668DC-5AE4-4ED7-9A91-F007E83F03E5

P2093

Q34307959-1DC70308-FE2E-44E8-985F-4518146DA2CD

Q34307959-24A854B9-9538-4B76-9D62-39651A487B88

Q34307959-305E83DC-47C1-414A-953E-BA69EF6C4F35

Q34307959-587B7402-1142-4C57-87FF-93B3731D0A62

Q34307959-A465CC12-10F6-44A7-AEB3-59B2F34A89E3

Q34307959-E018D142-8C2A-40C9-8E42-06A4DC7A9482

P2860

Q34307959-19D29B2C-9327-4B63-ADA4-B5204C48172B

Q34307959-2A6847FD-D7C9-4FA5-8304-05C6F5BA35D5

Q34307959-2DC46F85-BBE4-4795-81A8-8904E187BCC9

Q34307959-350FCA09-63DF-4C4D-8204-453312ADBA3A

Q34307959-389FF9D6-73B8-4971-B219-59645D134D9B

Q34307959-38E26A5C-1EFB-4B8C-A842-8C53D85561AC

Q34307959-3D0942AD-E5CD-4174-889E-534590FE7CB3

Q34307959-48340E6C-D2EE-4339-84F0-A0217A5DCFAA

Q34307959-4ED20AB6-2CCC-4A93-AD12-56649E55E851

Q34307959-5AE9DE57-43C5-4E27-9F7F-6145CDDD854D

P304

Q34307959-04088DAC-25EF-4D74-AEE6-A4FE112F331F

P31

Q34307959-A8E49879-2D13-4236-A6FB-9D730C4D1A6D

P356

Q34307959-60B8621A-75D4-41D1-AEB7-2E56B3E48F2F

P433

Q34307959-597A5F7C-F68A-4DA5-8890-59BCFD4736A1

P478

Q34307959-732572B7-1ABA-4291-BCD6-6F63EA99A40B

P577

Q34307959-7FAFED9E-2DF3-4920-8200-6D1F4F465C49

P5875

Q34307959-17542410-BD3F-4B8A-B4DF-55A15C0420ED

P698

Q34307959-FBAA17AF-D0AF-4493-99B8-509C75962BB0

P932

Q34307959-185D648A-903E-432F-936A-BC1C1358515F

P356

P1433

Cardiovascular Research

P1476

Novel role of Egr-1 in nicotine-related neointimal formation.

@en

P2093

Dania Mateu

http://www.w3.org/2001/XMLSchema#string

Keith A Webster

http://www.w3.org/2001/XMLSchema#string

Luis Rodriguez-Menocal

http://www.w3.org/2001/XMLSchema#string

Roberto I Vazquez-Padron

http://www.w3.org/2001/XMLSchema#string

Si M Pham

http://www.w3.org/2001/XMLSchema#string

Yuntao Wei

http://www.w3.org/2001/XMLSchema#string

P2860

A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors

Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes

Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation

A comparison of balloon injury models of endovascular lesions in rat arteries.

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Mammalian MAP kinase signalling cascades

Chronic nicotine exposure enhances insulin-induced mitogenic signaling via up-regulation of alpha7 nicotinic receptors in isolated rat aortic smooth muscle cells

Molecular regulation of vascular smooth muscle cell differentiation in development and disease

Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity?

Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways

P304

296-303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVQ213

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45113455

http://www.w3.org/2001/XMLSchema#string

P698

20615913

http://www.w3.org/2001/XMLSchema#string

P932

2980942

http://www.w3.org/2001/XMLSchema#string